Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity

Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity

US Patent 9518050 · Granted Dec 13, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combinations comprising MABA compounds and corticosteroids2019
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2019
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2019
Amino-substituted heterocyclic derivatives as sodium channel inhibitors2019
Aminoindazole derivatives as sodium channel inhibitors2019
Aminoindazole derivatives as sodium channel inhibitors2019
Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist a2018
Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist a2018
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2017
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2017
Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic an2017
Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic an2017